Analysis of clinical evaluation of response to treatment of Parkinson’s disease with integrated Chinese and Western medicine therapy
Authors:
- 10 June 2014
- journal article
- research article
- Published by Springer Nature in Chinese Journal of Integrative Medicine
- Vol. 21 (1) , 17-21
Abstract
To analyze the clinical evaluation of Parkinson’s disease (PD) patients receiving integrated Chinese and Western medicine therapy.Keywords
This publication has 12 references indexed in Scilit:
- Effects of Chinese herbal medicine Bushen Huoxue Granule on quality of life of patients with Parkinson disease: a randomized, double-blinded and placebo-controlled trialJournal of Chinese Integrative Medicine, 2012
- [Effects of "attenuation and synergia" for Bushenhuoxue Granules on Parkinson's patients].2012
- A multi-center randomized double-blind placebo-controlled trial of Xiongshao Capsule (芎芍胶囊) in preventing restenosis after percutaneous coronary intervention: A subgroup analysis of senile patientsChinese Journal of Integrative Medicine, 2011
- Biomarkers for Parkinson’s DiseaseScience Translational Medicine, 2011
- The development and validation of a new comprehensive self-completing questionnaire for symptoms in Parkinson's disease (MASAC-PD 31)Rinsho Shinkeigaku, 2011
- Nocturnal symptom complex in PD and its managementNeurology, 2003
- Test–Retest reliability of the Unified Parkinson's Disease Rating Scale in patients with early Parkinson's disease: Results from a multicenter clinical trialMovement Disorders, 2002
- Improved accuracy of clinical diagnosis of Lewy body Parkinson’s diseaseNeurology, 2001
- Progression of Hoehn and Yahr stages in parkinsonian disorders: A clinicopathologic studyNeurology, 2000
- The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1988